Don't want to miss the best from Business Standard?
Themis Medicare today said its Haridwar facility in Uttarakhand has received European Union-Good Manufacturing Practice (EU-GMP) certificate for oral and topical manufacturing sections.
"With this, the company can commercialise its products in the European Union (EU) countries," Themis Medicare said in a filing to BSE.
As per the European Medicines Agency, any manufacturer of medicines intended for the EU market, must comply with GMP.
The certification will also give access to the company to commercialise its products from the plant in the Pharmaceutical Inspection Co-operation Scheme (PICS) markets, Themis Medicare said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app